Apixaban and Ardeparin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Ardeparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines thin your blood. Apixaban (Eliquis) and ardeparin are both blood thinners, just working in slightly different ways. Taking them together means your blood is thinned more than with either one alone, so your risk of bleeding goes up. In studies, adding a similar injectable blood thinner raised apixaban's blood-thinning activity by about 50 to 60 percent.
Watch for unusual bruising, pink or red urine, black stools, nosebleeds, or bleeding that won't stop. If you see heavy or unexpected bleeding, get medical help right away. The good news: your care team knows about this combination and can manage it safely by monitoring you closely.
Additive anticoagulation. Apixaban (direct factor Xa inhibitor) plus ardeparin (LMWH) produces overlapping antithrombotic effects and increased bleeding risk. Neither is a prodrug; this is a pharmacodynamic, not metabolic, interaction.
- Magnitude: analogous pairing (apixaban + enoxaparin) increased anti-Xa activity 50 to 60 percent.
- Evidence: probable; severity major.
- Management: avoid overlap unless clearly indicated; discontinue apixaban if active pathological bleeding occurs. Apixaban PD effect persists at least 24 h post-dose. A specific reversal agent is available; PCC, aPCC, or rFVIIa may be considered. Note clotting assays/anti-Xa are not useful for monitoring reversal when PCCs are used.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
When apixaban, an inhibitor of factor Xa, is given together with another anticoagulant, the likelihood of bleeding rises. Pharmacodynamic interaction studies involving apixaban showed that giving apixaban alongside enoxaparin produced a 50% to 60% rise in anti-factor Xa activity. If active pathological bleeding develops, apixaban should be stopped. There is an available agent that reverses the anti-factor Xa activity of apixaban. Apixaban's pharmacodynamic effect is anticipated to remain for a minimum of 24 hours following the final dose. Patients should be informed about the signs and symptoms of blood loss and instructed to report them without delay or to present to an emergency room. Prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa may be considered as options. If PCCs are administered, it is neither useful nor recommended to monitor apixaban's anticoagulation effect through a clotting test (PT, INR, or aPTT) or through anti-factor Xa (FXa) activity. Absorption of apixaban is decreased by activated oral charcoal, which consequently reduces apixaban exposure1.
Why it happens (mechanism)
Additive anticoagulation
How to manage this interaction
Keep taking both exactly as prescribed unless your prescriber tells you otherwise. This combination is used deliberately in some situations, but it needs closer oversight because bleeding risk is higher.
- Learn the signs of blood loss: unusual bruising, blood in urine or stool, black tarry stools, prolonged bleeding, severe headache, or dizziness.
- Report any of these immediately or go to an emergency room.
- Your care team can adjust and individualize therapy and may monitor you more closely.
- A reversal agent for apixaban is available, and its effect can persist at least 24 hours after the last dose.
Ask your pharmacist or prescriber before starting or stopping either drug.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In investigations examining pharmacodynamic drug interactions involving apixaban, a 50% to 60% rise in anti-factor Xa activity was seen when apixaban and enoxaparin were given together 1.
Common questions
Can I take Apixaban and Ardeparin together?
Apixaban and ardeparin are both blood thinners, so using them together clearly raises bleeding risk. Take both only as prescribed, watch for any unusual bleeding, and get emergency help if it happens. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Apixaban and Ardeparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Apixaban and Ardeparin interaction managed?
Keep taking both exactly as prescribed unless your prescriber tells you otherwise. This combination is used deliberately in some situations, but it needs closer oversight because bleeding risk is higher. Learn the signs of blood loss: unusual bruising, blood in urine or stool, black tarry stools, prolonged bleeding, severe headache, or dizziness. Report any of these immediately or go to an emergen… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Apixaban or Ardeparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Apixaban
Keep reading about Ardeparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist